[
  {
    "cvxCode": "24",
    "shortDescription": "Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis",
    "fullName": "Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2024/01/25"
  },
  {
    "cvxCode": "19",
    "shortDescription": "BCG",
    "fullName": "Bacillus Calmette-Guerin vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "56",
    "shortDescription": "dengue fever tetravalent",
    "fullName": "dengue fever vaccine, tetravalent",
    "notes": "Applies to tetravalent product (e.g. DENGVAXIA)",
    "status": "Active",
    "lastUpdated": "2024/12/11"
  },
  {
    "cvxCode": "20",
    "shortDescription": "DTaP",
    "fullName": "diphtheria, tetanus toxoids and acellular pertussis vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "106",
    "shortDescription": "DTaP, 5 pertussis antigens",
    "fullName": "diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "110",
    "shortDescription": "DTaP-Hep B-IPV",
    "fullName": "DTaP-hepatitis B and poliovirus vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "120",
    "shortDescription": "DTaP-Hib-IPV",
    "fullName": "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "130",
    "shortDescription": "DTaP-IPV",
    "fullName": "Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "52",
    "shortDescription": "Hep A, adult",
    "fullName": "hepatitis A vaccine, adult dosage",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "83",
    "shortDescription": "Hep A, ped/adol, 2 dose",
    "fullName": "hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "104",
    "shortDescription": "Hep A-Hep B",
    "fullName": "hepatitis A and hepatitis B vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "08",
    "shortDescription": "Hep B, adolescent or pediatric",
    "fullName": "hepatitis B vaccine, pediatric or pediatric/adolescent dosage",
    "notes": "This code applies to any standard pediatric formulation of Hepatitis B vaccine. It should not be used for the 2-dose hepatitis B schedule for adolescents (11-15 year olds). Use code 43 for that vaccine.",
    "status": "Active",
    "lastUpdated": "2024/12/16"
  },
  {
    "cvxCode": "43",
    "shortDescription": "Hep B, adult",
    "fullName": "hepatitis B vaccine, adult dosage",
    "notes": "This code applies to any standard adult dose and schedule. Also use CVX 43 for the FDA approved Recombivax HB 2-dose hepatitis B schedule for adolescents (11-15 year olds) using the adult formulation.",
    "status": "Active",
    "lastUpdated": "2024/12/12"
  },
  {
    "cvxCode": "44",
    "shortDescription": "Hep B, high-dosage, dialysis or IC",
    "fullName": "Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient",
    "notes": "This code is used record patient high dosage vaccine administration for dialysis or immunocompromised patients. For NDCs that are used for both regular vaccine and dialysis/IC high-dosage schedules (e.g. Engerix-B), are mapped to both CVX 43 and CVX 44. CVX code 44 should be utilized to record dialysis/IC dosing.",
    "status": "Active",
    "lastUpdated": "2024/12/13"
  },
  {
    "cvxCode": "48",
    "shortDescription": "Hib (PRP-T)",
    "fullName": "Haemophilus influenzae type b vaccine, PRP-T conjugate",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "49",
    "shortDescription": "Hib (PRP-OMP)",
    "fullName": "Haemophilus influenzae type b vaccine, PRP-OMP conjugate",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "62",
    "shortDescription": "HPV, quadrivalent",
    "fullName": "human papilloma virus vaccine, quadrivalent",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2020/06/02"
  },
  {
    "cvxCode": "111",
    "shortDescription": "Influenza, live, trivalent, intranasal, PF",
    "fullName": "Influenza, live, trivalent, intranasal, preservative free",
    "notes": "HCP administered, trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2025/07/15"
  },
  {
    "cvxCode": "10",
    "shortDescription": "IPV",
    "fullName": "poliovirus vaccine, inactivated",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "03",
    "shortDescription": "MMR",
    "fullName": "measles, mumps and rubella virus vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "94",
    "shortDescription": "MMRV",
    "fullName": "measles, mumps, rubella, and varicella virus vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "114",
    "shortDescription": "meningococcal MCV4P",
    "fullName": "meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "33",
    "shortDescription": "pneumococcal polysaccharide PPV23",
    "fullName": "pneumococcal polysaccharide vaccine, 23 valent",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "119",
    "shortDescription": "rotavirus, monovalent",
    "fullName": "rotavirus, live, monovalent vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "116",
    "shortDescription": "rotavirus, pentavalent",
    "fullName": "rotavirus, live, pentavalent vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "113",
    "shortDescription": "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed",
    "fullName": "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2024/01/25"
  },
  {
    "cvxCode": "09",
    "shortDescription": "Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed",
    "fullName": "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2017/10/27"
  },
  {
    "cvxCode": "115",
    "shortDescription": "Tdap",
    "fullName": "tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "25",
    "shortDescription": "typhoid, oral",
    "fullName": "typhoid vaccine, live, oral",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "101",
    "shortDescription": "typhoid, ViCPs",
    "fullName": "typhoid Vi capsular polysaccharide vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "75",
    "shortDescription": "Vaccinia (smallpox, mpox), live",
    "fullName": "Vaccinia (smallpox, mpox) vaccine, live",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2025/04/30"
  },
  {
    "cvxCode": "21",
    "shortDescription": "varicella",
    "fullName": "varicella virus vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "37",
    "shortDescription": "yellow fever live",
    "fullName": "yellow fever vaccine live",
    "notes": "This is the YF vaccine that has been available in the US for years. It is stabilized with sorbitol and gelatin.",
    "status": "Active",
    "lastUpdated": "2024/03/07"
  },
  {
    "cvxCode": "133",
    "shortDescription": "Pneumococcal conjugate PCV 13",
    "fullName": "pneumococcal conjugate vaccine, 13 valent",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "134",
    "shortDescription": "Japanese Encephalitis IM",
    "fullName": "Japanese Encephalitis vaccine for intramuscular administration",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "136",
    "shortDescription": "Meningococcal MCV4O",
    "fullName": "meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2010/05/28"
  },
  {
    "cvxCode": "135",
    "shortDescription": "Influenza, high-dose, trivalent, PF",
    "fullName": "Influenza, high-dose, split virus, trivalent, injectable, preservative free",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/02"
  },
  {
    "cvxCode": "140",
    "shortDescription": "Influenza, split virus, trivalent, PF",
    "fullName": "Influenza, split virus, trivalent, injectable, preservative free",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/02"
  },
  {
    "cvxCode": "141",
    "shortDescription": "Influenza, split virus, trivalent, preservative",
    "fullName": "Influenza, split virus, trivalent, injectable, contains preservative",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/02"
  },
  {
    "cvxCode": "143",
    "shortDescription": "Adenovirus types 4 and 7",
    "fullName": "Adenovirus, type 4 and type 7, live, oral",
    "notes": "This vaccine is administered as 2 tablets.",
    "status": "Active",
    "lastUpdated": "2011/03/20"
  },
  {
    "cvxCode": "146",
    "shortDescription": "DTaP,IPV,Hib,HepB",
    "fullName": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.",
    "notes": "This vaccine is different from CVX 132. Code may be used to document non-US vaccines (e.g. Hexamin) of the same component formulation",
    "status": "Active",
    "lastUpdated": "2022/08/10"
  },
  {
    "cvxCode": "149",
    "shortDescription": "Influenza, live, quadrivalent, intranasal",
    "fullName": "Influenza, live, quadrivalent, intranasal",
    "notes": "Quadrivalent code starting 2013/2014 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "150",
    "shortDescription": "Influenza, split virus, quadrivalent, PF",
    "fullName": "Influenza, split virus, quadrivalent, injectable, preservative free",
    "notes": "Quadrivalent code starting 2013/2014 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "153",
    "shortDescription": "Influenza, MDCK, trivalent, PF",
    "fullName": "Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/06"
  },
  {
    "cvxCode": "155",
    "shortDescription": "Influenza, recombinant, trivalent, PF",
    "fullName": "Influenza, recombinant, trivalent, injectable, preservative free",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/06"
  },
  {
    "cvxCode": "158",
    "shortDescription": "Influenza, split virus, quadrivalent, preservative",
    "fullName": "Influenza, split virus, quadrivalent, injectable, contains preservative",
    "notes": "Quadrivalent code starting 2013/2014 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "160",
    "shortDescription": "Influenza A monovalent (H5N1), ADJUVANTED-2013",
    "fullName": "Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013",
    "notes": "Approved by FDA 2013, adjuvant is mixed at point of administration.",
    "status": "Active",
    "lastUpdated": "2014/05/27"
  },
  {
    "cvxCode": "161",
    "shortDescription": "Influenza, injectable,quadrivalent, preservative free, pediatric",
    "fullName": "Influenza, injectable,quadrivalent, preservative free, pediatric",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2024/07/29"
  },
  {
    "cvxCode": "162",
    "shortDescription": "meningococcal B, recombinant",
    "fullName": "meningococcal B vaccine, fully recombinant",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2014/11/03"
  },
  {
    "cvxCode": "163",
    "shortDescription": "meningococcal B, OMV",
    "fullName": "meningococcal B vaccine, recombinant, OMV, adjuvanted",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2015/02/02"
  },
  {
    "cvxCode": "165",
    "shortDescription": "HPV9",
    "fullName": "Human Papillomavirus 9-valent vaccine",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2014/12/11"
  },
  {
    "cvxCode": "168",
    "shortDescription": "Influenza, adjuvanted, trivalent, PF",
    "fullName": "Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free",
    "notes": "Trivalent code reactivated for 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/06"
  },
  {
    "cvxCode": "171",
    "shortDescription": "Influenza, MDCK, quadrivalent, PF",
    "fullName": "Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free",
    "notes": "Quadrivalent code starting 2016/2017 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "174",
    "shortDescription": "cholera, live attenuated",
    "fullName": "cholera, live attenuated",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2016/06/17"
  },
  {
    "cvxCode": "175",
    "shortDescription": "Rabies - IM Diploid cell culture",
    "fullName": "Human Rabies vaccine from human diploid cell culture",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2016/10/18"
  },
  {
    "cvxCode": "176",
    "shortDescription": "Rabies - IM fibroblast culture",
    "fullName": "Human rabies vaccine from Chicken fibroblast culture",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2016/10/18"
  },
  {
    "cvxCode": "183",
    "shortDescription": "Yellow fever vaccine live - alt",
    "fullName": "Yellow fever vaccine live - alternative formulation for vaccine shortage",
    "notes": "This CVX is associated to an FDA unapproved drug to be used when there is a drug shortage. Stabilized with sorbitol and lactose and has been used outside the US for some time.",
    "status": "Active",
    "lastUpdated": "2024/03/07"
  },
  {
    "cvxCode": "185",
    "shortDescription": "Influenza, recombinant, quadrivalent, PF",
    "fullName": "Influenza, recombinant, quadrivalent, injectable, preservative free",
    "notes": "Quadrivalent code starting 2017/2018 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "186",
    "shortDescription": "Influenza, MDCK, quadrivalent, preservative",
    "fullName": "Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative",
    "notes": "Quadrivalent code starting 2017/2018 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "187",
    "shortDescription": "zoster recombinant",
    "fullName": "zoster vaccine recombinant",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2017/10/27"
  },
  {
    "cvxCode": "189",
    "shortDescription": "HepB-CpG",
    "fullName": "Hepatitis B vaccine (recombinant), CpG adjuvanted",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2018/05/10"
  },
  {
    "cvxCode": "196",
    "shortDescription": "Td, adsorbed, preservative free, adult use, Lf unspecified",
    "fullName": "tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified",
    "notes": "Used when Td Lf specification is unknown",
    "status": "Active",
    "lastUpdated": "2019/08/15"
  },
  {
    "cvxCode": "197",
    "shortDescription": "Influenza, high-dose, quadrivalent, PF",
    "fullName": "Influenza, high-dose, split virus, quadrivalent, injectable, preservative free",
    "notes": "Quadrivalent code starting season 2020/2021",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "200",
    "shortDescription": "influenza, Southern Hemisphere, pediatric, preservative free",
    "fullName": "influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free",
    "notes": "Pediatric dose for ages 6-35 months",
    "status": "Active",
    "lastUpdated": "2023/01/17"
  },
  {
    "cvxCode": "201",
    "shortDescription": "Influenza, Southern Hemisphere, quadrivalent, PF",
    "fullName": "Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free",
    "notes": "Represents single dose vial",
    "status": "Active",
    "lastUpdated": "2025/04/22"
  },
  {
    "cvxCode": "202",
    "shortDescription": "influenza, Southern Hemisphere, quadrivalent, with preservative",
    "fullName": "influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative",
    "notes": "Represents multi-dose vial",
    "status": "Active",
    "lastUpdated": "2023/01/17"
  },
  {
    "cvxCode": "203",
    "shortDescription": "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)",
    "fullName": "meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2023/01/26"
  },
  {
    "cvxCode": "205",
    "shortDescription": "Influenza, adjuvanted, quadrivalent, PF",
    "fullName": "Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free",
    "notes": "Quadrivalent code starting 2020/2021 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "206",
    "shortDescription": "Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection",
    "fullName": "Vaccinia, smallpox mpox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection",
    "notes": "Associated to FDA US Licensed product JYNNEOS, non-US tradenames IMVANEX, IMVAMUNE. Review CDC & FDA guidance for updates regarding administration",
    "status": "Active",
    "lastUpdated": "2025/08/26"
  },
  {
    "cvxCode": "204",
    "shortDescription": "Ebola Zaire vaccine, live, recombinant, 1mL dose",
    "fullName": "Ebola Zaire vaccine, live, recombinant, 1mL dose",
    "notes": "FDA Approved ERVEBO Vaccine.",
    "status": "Active",
    "lastUpdated": "2024/01/03"
  },
  {
    "cvxCode": "215",
    "shortDescription": "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF",
    "fullName": "Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2021/08/18"
  },
  {
    "cvxCode": "216",
    "shortDescription": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
    "fullName": "Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2023/03/09"
  },
  {
    "cvxCode": "223",
    "shortDescription": "Tick-borne encephalitis, inactivated, PF, 0.25mL",
    "fullName": "Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose",
    "notes": "Pediatric dose vaccine",
    "status": "Active",
    "lastUpdated": "2022/03/03"
  },
  {
    "cvxCode": "224",
    "shortDescription": "Tick-borne encephalitis, inactivated, PF, 0.5mL",
    "fullName": "Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose",
    "notes": "Adult dose vaccine",
    "status": "Active",
    "lastUpdated": "2022/03/04"
  },
  {
    "cvxCode": "231",
    "shortDescription": "influenza, Southern Hemisphere, high-dose, quadrivalent",
    "fullName": "influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free",
    "notes": "Target population 65 and older, starting Southern Hemisphere season 2023",
    "status": "Active",
    "lastUpdated": "2023/03/14"
  },
  {
    "cvxCode": "303",
    "shortDescription": "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF",
    "fullName": "Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free",
    "notes": "Adults 60 years and older",
    "status": "Active",
    "lastUpdated": "2023/06/06"
  },
  {
    "cvxCode": "305",
    "shortDescription": "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF",
    "fullName": "Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free",
    "notes": "Adults 60 years and older, pregnant individuals",
    "status": "Active",
    "lastUpdated": "2024/08/07"
  },
  {
    "cvxCode": "306",
    "shortDescription": "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months",
    "fullName": "Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months",
    "notes": "RSV monoclonal antibody (Beyfortus)",
    "status": "Active",
    "lastUpdated": "2023/07/25"
  },
  {
    "cvxCode": "307",
    "shortDescription": "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months",
    "fullName": "Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months",
    "notes": "RSV monoclonal antibody (Beyfortus)",
    "status": "Active",
    "lastUpdated": "2023/08/09"
  },
  {
    "cvxCode": "313",
    "shortDescription": "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose",
    "notes": "Novavax Fall Seasonal 12 years and older",
    "status": "Active",
    "lastUpdated": "2024/09/05"
  },
  {
    "cvxCode": "309",
    "shortDescription": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose",
    "notes": "Pfizer Fall Seasonal 12 years and older",
    "status": "Active",
    "lastUpdated": "2024/08/30"
  },
  {
    "cvxCode": "310",
    "shortDescription": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose",
    "notes": "Pfizer Fall Seasonal 5 years through 11 years of age",
    "status": "Active",
    "lastUpdated": "2024/08/30"
  },
  {
    "cvxCode": "312",
    "shortDescription": "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose",
    "notes": "Moderna Fall Seasonal 12 years and older",
    "status": "Active",
    "lastUpdated": "2024/08/30"
  },
  {
    "cvxCode": "311",
    "shortDescription": "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose",
    "notes": "Moderna Fall Seasonal 6 months through 11 years of age",
    "status": "Active",
    "lastUpdated": "2024/08/30"
  },
  {
    "cvxCode": "316",
    "shortDescription": "Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF",
    "fullName": "Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free",
    "notes": "Meningococcal pentavalent vaccine strains ABCW and Y",
    "status": "Active",
    "lastUpdated": "2024/01/25"
  },
  {
    "cvxCode": "317",
    "shortDescription": "Chikungunya live attenuated vaccine, 0.5 mL, PF",
    "fullName": "Chikungunya, live attenuated vaccine, 0.5 mL, preservative free",
    "notes": "Chikungunya Vaccine",
    "status": "Active",
    "lastUpdated": "2023/12/20"
  },
  {
    "cvxCode": "318",
    "shortDescription": "Anthrax, post-exposure prophylaxis",
    "fullName": "Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis",
    "notes": "National stockpile vaccine (Cyfendus)",
    "status": "Active",
    "lastUpdated": "2024/01/25"
  },
  {
    "cvxCode": "320",
    "shortDescription": "Influenza, MDCK, trivalent, preservative",
    "fullName": "Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative",
    "notes": "Trivalent code starting 2024/2025 season",
    "status": "Active",
    "lastUpdated": "2024/05/15"
  },
  {
    "cvxCode": "321",
    "shortDescription": "Influenza-avian, H5N8, monovalent, PF",
    "fullName": "Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free",
    "notes": "Novel Bird Flu H5N8 Vaccine 2024",
    "status": "Active",
    "lastUpdated": "2024/06/12"
  },
  {
    "cvxCode": "322",
    "shortDescription": "Influenza-avian, H5N8, monovalent, preservative",
    "fullName": "Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative",
    "notes": "Novel Bird Flu H5N8 Vaccine 2024",
    "status": "Active",
    "lastUpdated": "2024/06/12"
  },
  {
    "cvxCode": "326",
    "shortDescription": "RSV, mRNA, injectable, PF",
    "fullName": "Respiratory syncytial virus (RSV), mRNA, injectable, preservative free",
    "notes": "mRNA RSV vaccine added 2024",
    "status": "Active",
    "lastUpdated": "2024/08/30"
  },
  {
    "cvxCode": "327",
    "shortDescription": "Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF",
    "fullName": "Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2024/07/11"
  },
  {
    "cvxCode": "328",
    "shortDescription": "Meningococcal oligosaccharide (MenACWY), (MenB), PF",
    "fullName": "Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free",
    "notes": "Meningococcal pentavalent vaccine strains ABCW and Y",
    "status": "Active",
    "lastUpdated": "2025/03/18"
  },
  {
    "cvxCode": "329",
    "shortDescription": "Chikungunya, VLP, recombinant, 0.8 mL, PF",
    "fullName": "Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free",
    "notes": "",
    "status": "Active",
    "lastUpdated": "2025/03/18"
  },
  {
    "cvxCode": "331",
    "shortDescription": "Influenza, Southern Hemisphere, trivalent, PF",
    "fullName": "Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free",
    "notes": "Represents single dose vial",
    "status": "Active",
    "lastUpdated": "2025/04/30"
  },
  {
    "cvxCode": "332",
    "shortDescription": "RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF",
    "fullName": "Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free",
    "notes": "RSV mAb for neonates and infants born during or entering first RSV season (Enflonsia)",
    "status": "Active",
    "lastUpdated": "2025/07/03"
  },
  {
    "cvxCode": "333",
    "shortDescription": "Influenza, live, trivalent, intranasal, self/caregiver admin, PF",
    "fullName": "Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free",
    "notes": "Self or caregiver administered, new starting 2025/2026 season",
    "status": "Active",
    "lastUpdated": "2025/07/15"
  },
  {
    "cvxCode": "334",
    "shortDescription": "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL",
    "fullName": "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose",
    "notes": "Moderna monovalent new formulation mNEXSPIKE, starting Fall 2025, ages 12 yrs and older, BLA",
    "status": "Active",
    "lastUpdated": "2025/08/28"
  }
]